Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002394430 | SCV002699384 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2022-09-25 | criteria provided, single submitter | clinical testing | The p.A482T variant (also known as c.1444G>A), located in coding exon 13 of the LZTR1 gene, results from a G to A substitution at nucleotide position 1444. The alanine at codon 482 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005025816 | SCV005656753 | uncertain significance | Noonan syndrome 2; LZTR1-related schwannomatosis; Noonan syndrome 10 | 2024-06-21 | criteria provided, single submitter | clinical testing |